Sign In
Buy CODX
$5.17
-1.05 (-16.88%)
At Close: Jun 03, 2026
Co-Diagnostics turns fight against infectious disease with flagship coronavirus (COVID-19) test
03:55pm, Friday, 26'th Mar 2021
Develops products to detect infectious diseases in humans and animals Offers Logix Smart Coronavirus Disease detection test in US and globally Earned net income of $42.5 million in 2020 What Co-Diag
Why Co-Diagnostics Stock Is Tanking Today
10:40am, Friday, 26'th Mar 2021
Investors didn't like what they heard in the company's fourth-quarter update.
What Investors Didn't Like About Co-Diagnostics' Q4 Update
06:00am, Friday, 26'th Mar 2021
The company missed earnings expectations and hinted at slowing growth in 2021.
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q4 2020 Results - Earnings Call Transcript
10:12pm, Thursday, 25'th Mar 2021
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q4 2020 Results - Earnings Call Transcript
CoDiagnostics, Inc. (CODX) Q4 Earnings Lag Estimates
06:11pm, Thursday, 25'th Mar 2021
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -12.24% and 1.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics posts 2020 net income of $42.5M as its Logix Smart COVID-19 test drove record sales
04:26pm, Thursday, 25'th Mar 2021
Co-Diagnostics Inc (NASDAQ:CODX) announced Thursday that it earned a net income of $42.5 million in 2020 as its Logix Smart coronavirus (COVID-19) test drove record sales. That's a huge turnaround f
Recap: Co-Diagnostics Q4 Earnings
04:19pm, Thursday, 25'th Mar 2021
Shares of Co-Diagnostics (NASDAQ:CODX) moved lower in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 577.78% year over year to $0.43, which m
Co-Diagnostics Reports Fourth-Quarter and Full-Year 2020 Financial Results
04:01pm, Thursday, 25'th Mar 2021
SALT LAKE CITY, March 25, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (NASDAQ: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests
Co-Diagnostics Stock Is an Out-and-Out Buy Before the Earnings Release
11:20am, Thursday, 25'th Mar 2021
CODX stock's true value isn't fully appreciated by the investing community, and this could provide a setup for an explosive move. The post Co-Diagnostics Stock Is an Out-and-Out Buy Before the Earning
Co-Diagnostics, Inc. Announces Fourth-Quarter and Full-Year 2020 Earnings Release Date and Webcast
08:30am, Thursday, 18'th Mar 2021
SALT LAKE CITY, March 18, 2021 /PRNewswire/ -- Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests,
Co-Diagnostics: A+ Student Faces New Tests
10:45am, Friday, 12'th Mar 2021
Co-Diagnostics: A+ Student Faces New Tests
Biotech Stocks: What Will 2021 Look Like?
06:00am, Friday, 12'th Mar 2021
2020 was a wild run for the biotech sector, with COVID-19 dominating the headlines. What will happen this year?
Co-Diagnostics is designing at-home coronavirus PCR saliva test delivering results by smartphone app
03:50pm, Tuesday, 02'nd Mar 2021
Co-Diagnostics Inc (NASDAQ:CODX) has announced the development of a new at-home PCR-based coronavirus (COVID-19) testing, screening and surveillance platform that delivers rapid results via smartphone
Co-Diagnostics designs at-home coronavirus PCR saliva test delivering results by smartphone app
12:01pm, Tuesday, 02'nd Mar 2021
Co-Diagnostics Inc (NASDAQ:CODX) has announced the development of a new at-home PCR-based coronavirus (COVID-19) testing, screening and surveillance platform that delivers rapid results via smartphone
Co-Diagnostics notes its CoPrimer technology powers coronavirus saliva test now available through Walgreens digital health platform
10:23am, Thursday, 25'th Feb 2021
Co-Diagnostics Inc (NASDAQ:CODX) has confirmed that its patented CoPrimer technology is part of a coronavirus (COVID-19) saliva test that is now available through Walgreens Find Care, a digital healt
